-->

Compass CEO Kabir Nath quit high-paying job to work on psychedelic pill for treating depression

Kabir Nath left pharma to lead Compass Pathways’ development of COMP360, a synthetic psilocybin treatment for treatment-resistant depression. 

Previous article
Next article

0 Response to "Compass CEO Kabir Nath quit high-paying job to work on psychedelic pill for treating depression"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel